Merrimack Pharmaceuticals Inc (NASDAQ:MACK)
| 14.26 Delayed Data As of 3:59pm ET |  -0.64 / -4.30%Today’s Change | 11.30 Today|||52-Week Range 46.19 | -48.62% Year-to-Date |
Latest MACK News | Press Releases
No recent news for Merrimack Pharmaceuticals Inc.
Today’s Trading
| Previous close | 14.90 |
| Today’s open | 14.96 |
| Day’s range | 13.98 - 15.09 |
| Volume | 190,933 |
| Average volume (3 months) | 260,749 |
| Market cap | -- |
| Dividend yield | 7.40% |
Data as of 3:59pm ET, 09/22/2017
Growth & Valuation
| Earnings growth (last year) | -- |
| Earnings growth (this year) | -- |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | -- |
| P/E ratio | NM |
| Price/Sales | -- |
| Price/Book | -- |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| CRHMCRH Medical Corp | +0.05 | +1.92% |
| OCULOcular Therapeutix I... | +0.04 | +0.63% |
| CLSDClearside Biomedical... | +0.15 | +1.84% |
| OCXOncoCyte Corp | -0.05 | -0.75% |
Data as of 4:09pm ET, 09/22/2017
Financials
| Next reporting date | -- |
| EPS forecast (this quarter) | -- |
| Annual revenue (last year) | -- |
| Annual profit (last year) | -- |
| Net profit margin | -- |
Profile
Sector -- |
Industry -- |
No executives to display |
Corporate headquarters --, -- |
Forecasts
